Anebulo Pharmaceuticals Stock Analysis

Anebulo Stock Analysis Notes

About 64.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.32. Anebulo Pharmaceuticals had not issued any dividends in recent years. Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing and commercializing treatments for people suffering from acute cannabinoid intoxication and substance addiction. The company was incorporated in 2020 and is based in Lakeway, Texas. Anebulo Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 4 people. For more info on Anebulo Pharmaceuticals please contact Richard Cunningham at 512 598 0931 or go to https://www.anebulo.com.

Anebulo Pharmaceuticals Investment Alerts

Anebulo Pharmaceuticals Upcoming and Recent Events

Anebulo Largest EPS Surprises

View All Earnings Estimates

Anebulo Stock Institutional Investors

Note, although Anebulo Pharmaceuticals' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Anebulo Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 42.79 M.

Anebulo Profitablity

Management Efficiency

Anebulo Pharmaceuticals has return on total asset (ROA) of (0.6597) % which means that it has lost $0.6597 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.138) %, meaning that it created substantial loss on money invested by shareholders. Anebulo Pharmaceuticals' management efficiency ratios could be used to measure how well Anebulo Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to -2.2. The current year's Return On Capital Employed is expected to grow to -2.38. At present, Anebulo Pharmaceuticals' Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Other Current Assets is expected to grow to about 565.7 K, whereas Total Assets are forecasted to decline to about 3.5 M.

Technical Drivers

As of the 31st of January, Anebulo Pharmaceuticals shows the risk adjusted performance of 0.0055, and Mean Deviation of 4.42. Anebulo Pharmaceuticals technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

Anebulo Pharmaceuticals Price Movement Analysis

Anebulo Pharmaceuticals Insider Trading Activities

Anebulo Pharmaceuticals Outstanding Bonds

Anebulo Pharmaceuticals Predictive Daily Indicators

Anebulo Pharmaceuticals Forecast Models

Anebulo Pharmaceuticals' time-series forecasting models are one of many Anebulo Pharmaceuticals' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Anebulo Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Anebulo Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Anebulo shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Anebulo Pharmaceuticals. By using and applying Anebulo Stock analysis, traders can create a robust methodology for identifying Anebulo entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Anebulo analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Anebulo analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Anebulo Pharmaceuticals stock analysis indicators help investors evaluate how Anebulo Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Anebulo Pharmaceuticals shares will generate the highest return on investment. By understating and applying Anebulo Pharmaceuticals stock analysis, traders can identify Anebulo Pharmaceuticals position entry and exit signals to maximize returns.

When running Anebulo Pharmaceuticals' price analysis, check to measure Anebulo Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Anebulo Pharmaceuticals is operating at the current time. Most of Anebulo Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Anebulo Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Anebulo Pharmaceuticals' price. Additionally, you may evaluate how the addition of Anebulo Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.